Dr. Brian King was appointed Director of the Food and Drug Administration’s Center for Tobacco Products (CTP) in July 2022. In this position, Dr. King is responsible for assuring that CTP accomplishes its public health goals and for operationalizing the Center’s vision and mission as it implements the Family Smoking Prevention and Tobacco Control Act.
Dr. King has worked for nearly two decades to provide sound scientific evidence to inform tobacco control policy and to effectively communicate this information to key stakeholders, including decision makers, the media, and the general public. Prior to joining FDA, he served as the Deputy Director for Research Translation in CDC’s Office on Smoking and Health, and more recently as the Executive Editor of CDC’s Morbidity & Mortality Weekly Report Series. He has authored more than 200 scientific journal articles related to tobacco prevention and control, served as Senior Associate Editor for multiple U.S. Surgeon General’s Reports on tobacco, and was lead author of CDC’s 2014 evidence-based guide, “Best Practices for Comprehensive Tobacco Control Programs.”
Dr. King holds a Ph.D. and M.P.H. in Epidemiology from the State University of New York at Buffalo.
- Describe the current patterns of tobacco product use among adults and youth in the United States.
- Identify FDA’s tobacco regulatory priorities, including application reviews, regulations and guidance, enforcement and compliance, and public health education campaigns.
- Explain future opportunities for tobacco product regulation in the United States, including planned product standards to prohibit menthol in cigarettes, to prohibit flavors in cigars, and to cap the maximum level of nicotine in cigarettes and certain other combusted products to minimally addictive or nonaddictive levels.
- Identify opportunities and resources to promote tobacco product use cessation.
CME/CE credit is no longer available for this activity. The CME/CE credit has expired.
Certificates of Attendance
Click here to generate a certificate of attendance for participating on this webinar.